CellaVision AB
STO:CEVI
CellaVision AB
STO:CEVI
Price:
227.5 SEK
0.89%
Market Closed
Updated:
May 3, 2024
CellaVision AB
Operating Income
|
CellaVision AB
Operating Income Peer Comparison
Comparables:
EKTA B
GETI B
ARJO B
ELOS B
SEDANA
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
CellaVision AB
STO:CEVI
|
Operating Income
kr167.1m
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
20%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Operating Income
kr2.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Getinge AB
STO:GETI B
|
Operating Income
kr4.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Operating Income
kr968m
|
CAGR 3-Years
1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Elos Medtech AB
STO:ELOS B
|
Operating Income
kr121.8m
|
CAGR 3-Years
23%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Operating Income
-kr66.6m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
See Also
What is CellaVision AB's Operating Income?
Operating Income
167.1m
SEK
167.1m
SEK
Based on the financial report for Dec 31, 2023, CellaVision AB's Operating Income amounts to 167.1m SEK.
What is CellaVision AB's Operating Income growth rate?
Operating Income CAGR 10Y
20%
20%
Over the last year, the Operating Income growth was 3%. The average annual Operating Income growth rates for CellaVision AB have been 14% over the past three years , 8% over the past five years , and 20% over the past ten years .
You don't have any saved screeners yet
